EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study


American Journal of Epidemiology 106(5): 392-398
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study
Samples of blood donors and patients with non-liver diseases from 6 foreign countries and the USA (1297 subjects) were surveyed for antibody to hepatitis A antigen (anti-HA) by immune adherence hemagglutination and for antibody to hepatitis B surface antigen (anti-HBs) by AUSAB [ a radioimmunoassay]. The age-standardized anti-HA prevalence was 28.7% in Switzerland, 44.7% in the USA, 76.2% in Senegal, 81.1% in Belgium, 88.7% in Taiwan, 95.3% in Israel and 96.9% in Yugoslavia. Among subjects 18-19 yr of age only 5-10% of Swiss and Americans had anti-HA, whereas 92-100% of subjects in the same age group from Israel, Yugoslavia, Taiwan and Senegal had this antibody. A close correlation between anti-HA and anti-HBs prevalence was seen in 5 countries; however, in Belgium and Israel anti-HBs rates were low while anti-HA rates were very high. Apparently hepatitis A virus infections are widespread throughout the world and their occurrence and age-distribution are determined to a large extent by environmental and socioeconomic conditions, although other, as yet unidentified, factors are probably also important. In view of the unrepresentative nature of the population samples surveyed, these findings should be confirmed on other samples.


Accession: 006740225

PMID: 200139



Related references

Investigations on hepatitis b e antigen 1. prevalence of hepatitis b e antigen and anti hepatitis b e antibody in the stationary phase of hepatitis b surface antigen positive acute viral hepatitis. Revue Roumaine de Medecine Virologie 32(2): 93-98, 1981

Prevalence of hepatitis b e antigen antibody to hepatitis b e antigen and dane particle associated dna polymerase activity in asymptomatic carriers of hepatitis b surface antigen. Ricerca in Clinica e in Laboratorio 9(1): 35-40, 1979

Age specific prevalence of hepatitis b e antigen and antibody to hepatitis b e antigen among asymptomatic hepatitis b surface antigen carriers in okinawa and kyushu japan. Microbiology & Immunology 30(7): 675-682, 1986

Virological and serological study in children hospitalized for acute hepatitis detection of hepatitis b surface antigen hepatitis a antigen anti hepatitis a antibody and specific immuno globulin m anti hepatitis a antibody. Helvetica Paediatrica Acta 36(5): 429-436, 1981

A critical radio immunological study of the hepatitis be antigen anti hepatitis be antigen antibody system and anti hepatitis b core antigen antibody in chronic active hepatitis. Folia Allergologica et Immunologica Clinica 28(4): 316-321, 1981

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 33(3): 212-216, 1993

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis b surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion (bethesda). 33(3): 212-216, 1993

Prevalence of hepatitis b e antigen and antibody to hepatitis b e antigen in blood donors with hepatitis b surface antigen antigenemia. Revue Roumaine de Medecine Virologie 29(3): 209-212, 1978

The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Archives of Iranian Medicine 12(3): 225-231, 2009

Re: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Archives of Iranian Medicine 12(4): 437; Author Reply 437-8, 2009